Indeed, STAT3 is supposed to be a promising therapeutic target of novel anticancer drugs like methyl ester derivative of synthetic triterpenoid which have been tested in a relevant model of ER negative breast cancers [49]. Here, STAT3 is linked to breast carcinoma.